Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Binder who wrote (639)	5/2/1998 11:25:00 PM
From: Jeffrey L. Henken	Respond to of 2887

Binder, American BioMed actually has ten catheter designs approved for sale by the FDA including the Ahn Atherectomy Catheter. Four more versions of the bilumen catheter will be approved soon by the FDA. I think the website may actually be updated this week to reflect some of the tremendous progress the company is finally making. GO ABMI! Regards, Jeff

To: Binder who wrote (639)	5/3/1998 12:13:00 AM
From: okee-boy	Read Replies (1) \| Respond to of 2887

Binder, I hope everyone realizes the importance of this new advancement in catheters. As I see it, all systems in use now are multi functional systems. They can install stents, cut out plaque and help in diagnostic. I do not believe they can vacuum away the plaque. During the insertion procedure plaque is broken loose and can end up in the feet, kidneys or other parts of the body. In the feet it can clog the small vessels causing dry gangrene. In the kidneys it may shut down any kidney function resulting in dependence on dialysis. IMHO the vacuum advantage will save lives and be highly sought after by the medical community. I believe this to be a note worthy advancement. I truly wish it had been available for my father. Good investing all. okee-boy